{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:02:38Z","timestamp":1761512558239},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.yebeh.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T10:14:50Z","timestamp":1214388890000},"page":"554-556","source":"Crossref","is-referenced-by-count":9,"title":["Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy"],"prefix":"10.1016","volume":"13","author":[{"given":"Pradeep N.","family":"Modur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren E.","family":"Milteer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","article-title":"Pregabalin pharmacology and its relevance to clinical practice","volume":"45","author":"Ben-Menachem","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose\u2013response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1528-1167.2005.00341.x","article-title":"Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/j.1528-1167.2006.00862.x","article-title":"Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting","volume":"47","author":"Arain","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.seizure.2006.04.002","article-title":"Epilepsy in adults with intellectual disabilities: prevalence, associations and service implications","volume":"15","author":"McGrother","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1528-1157.1998.tb01163.x","article-title":"Intractable epilepsy in a population-based series of mentally retarded children","volume":"39","author":"Steffenburg","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1525-5050(02)00539-5","article-title":"Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs","volume":"3","author":"Rutecki","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.05.003_bib11","doi-asserted-by":"crossref","unstructured":"Commission. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1981;22:489\u2013501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"10.1016\/j.yebeh.2008.05.003_bib12","doi-asserted-by":"crossref","unstructured":"Commission. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1989;30:389\u2013399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"10.1016\/j.yebeh.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.seizure.2007.05.011","article-title":"Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice","volume":"16","author":"Carreno","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1528-1157.2001.44000.x","article-title":"Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin","volume":"42","author":"Huppertz","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yebeh.2007.06.012","article-title":"Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain","volume":"11","author":"Knake","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1528-1157.2000.tb00192.x","article-title":"Myoclonus associated with the use of gabapentin","volume":"41","author":"Asconape","year":"2000","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550500800108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550500800108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:28:48Z","timestamp":1709069328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550500800108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S152550500800108X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2008.05.003","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}